Metabolomics is study and analysis of biochemical processes involving intermediates and products of metabolic activity. The products are called as metabolomes that reflect a cluster of all metabolites involved in a reaction within an organism which includes metabolic intermediates, signaling molecules, secondary metabolites, and hormones.
Metabolomics includes utilization of various analytical processes for determination of metabolites which include spectroscopy, chromatography, and multivariate analysis. Metabolites are closely related to the phenotype of an organism and can be used for wide range of applications such as substantial equivalence testing and phenotyping of genetically modified plants, identification of gene function, and biotic-abiotic stress reaction analysis. Furthermore, it also allows researchers and scientists to calculate physiological effects and observe the adverse reaction of drugs on an organism.
Increased adoption of metabolomics in precision medicine, continues technological advances in medical devices is expected to drive the metabolomics market. Moreover, increased private and government funding for metabolomics R&D is expected to propel the metabolomics market in the analysis period. However, the high cost of analytical and equipment and their maintenance, and lack of effective data management is expected to encumber the market growth.
The metabolomics market is segmented based on product & services, applications, indications, and geography. Based on product and service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics instruments are further classified into separation tools (high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis) and detection technique (mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis). Metabolomics bioinformatics tools and services are further divided into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications. Based on indications, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications.
By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global metabolomics market.
The overall impact of COVID-19 on the metabolomics market was fairly positive. This was due to the fact that metabolomics was applied in research to study COVID-19 disease. For instance, metabolomics is used for analysis of volatile organic compounds exhaled by COVID-19 patients. Thus, this quality of metabolomics led to its applications in a large-scale screening of population in point-of-care (POC) setting. In addition, active research is also ongoing related to the discovery of potential metabolomics-based prognostic markers for COVID-19. Similarly, a number of metabolic pathways related to energy metabolism, amino acid, and lipids were found to be affected by severe disease with COVID-19.
Hence, the rise in demand of metabolomics products for COVID-19 related research lead to a surge in growth of market which in turn impacted the market in a positive manner. KEY BENEFITS FOR STAKEHOLDERS
Metabolomics includes utilization of various analytical processes for determination of metabolites which include spectroscopy, chromatography, and multivariate analysis. Metabolites are closely related to the phenotype of an organism and can be used for wide range of applications such as substantial equivalence testing and phenotyping of genetically modified plants, identification of gene function, and biotic-abiotic stress reaction analysis. Furthermore, it also allows researchers and scientists to calculate physiological effects and observe the adverse reaction of drugs on an organism.
Increased adoption of metabolomics in precision medicine, continues technological advances in medical devices is expected to drive the metabolomics market. Moreover, increased private and government funding for metabolomics R&D is expected to propel the metabolomics market in the analysis period. However, the high cost of analytical and equipment and their maintenance, and lack of effective data management is expected to encumber the market growth.
The metabolomics market is segmented based on product & services, applications, indications, and geography. Based on product and service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics instruments are further classified into separation tools (high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis) and detection technique (mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis). Metabolomics bioinformatics tools and services are further divided into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications. Based on indications, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications.
By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global metabolomics market.
The overall impact of COVID-19 on the metabolomics market was fairly positive. This was due to the fact that metabolomics was applied in research to study COVID-19 disease. For instance, metabolomics is used for analysis of volatile organic compounds exhaled by COVID-19 patients. Thus, this quality of metabolomics led to its applications in a large-scale screening of population in point-of-care (POC) setting. In addition, active research is also ongoing related to the discovery of potential metabolomics-based prognostic markers for COVID-19. Similarly, a number of metabolic pathways related to energy metabolism, amino acid, and lipids were found to be affected by severe disease with COVID-19.
Hence, the rise in demand of metabolomics products for COVID-19 related research lead to a surge in growth of market which in turn impacted the market in a positive manner. KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans
- A comprehensive analysis of the factors that drive and restrain the growth of the Metabolomics Market is provided
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves
KEY MARKET SEGMENTS
By Product and Service
- Metabolomics Instruments
- Separation Techniques
- High Performance Liquid Chromatography
- Gas Chromatography
- Ultra Performance Liquid chromatography
- Capillary Electrophoresis
- Detection Technique
- Mass Spectrometry
- Nuclear Magnetic Resonance Spectrometry
- Surface Based Mass Analysis
- Metabolomics Bioinformatic Tools and services
- Bioinformatic Services
- Bioinformatics Tools and Database
By Application
- Biomarkers Discovery
- Drug Discovery
- Nutrigenomics
- Toxivology Testing
- Functional Genomics
- Personalized Medicine
- Others
By Indication
- Cancer
- Cardiovascular Disease
- Neurological Disorders
- Inborn Errors of Metabolism
- Other
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Agilent Technologies, Inc
- Danaher Corporation
- Biocrates Life Sciences AG
- Bruker Corporation
- LECO Corporation
- Metabolon, Inc
- Human Metabolome Technologies, Inc
- Bio-Rad Laboratories, Inc
- Shimadzu Corporation
- Waters Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Metabolomics Market, by Product and Services
Chapter 5: Metabolomics Market, by Application
Chapter 6: Metabolomics Market, by Indication
Chapter 7: Metabolomics Market, by Region
Chapter 8: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Metabolomics Market by Product and Service, Application and Indication: Global Opportunity Analysis and Industry Forecast, 2021–2030,the global metabolomics market size was valued at $2,032 Million in 2020, and is estimated to reach $6,663 Million by 2030, growing at a CAGR of 12.2% from 2021 to 2030.Metabolomics includes the application of a variety of analytical methods such as spectroscopy, chromatography, and multivariate analysis for identification of quantification of various metabolites. The analytical methods facilitate classification of a multitude of known and unknown metabolites in the reaction. The comprehensive nature of metabolites can be applied in many fields and assist in the development of new treatment and diagnostics in human diseases.
Owing to increased adoption of metabolomics in precision medicine and upsurge in R&D investment metabolomics market is expected to grow at a productive rate in the analysis period. Moreover, technological advancement in auxiliary medical devices and growth in demand for the development of quality medications is expected to fuel the market. However, the high cost of medical devices and lack of effective data management obstruct the growth of metabolomics market.
The global metabolomics market is segmented based on product & service, application, indication, and region. Based on product & service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further divided into separation techniques and detection techniques. The separation techniques segment is further classified into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further categorized into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis.
The metabolomics bioinformatics tools & services segment is further bifurcated into bioinformatics tools & databases and bioinformatics services. Based on application, the metabolomics market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Based on indication, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The COVID-19 was declared as a pandemic in the start of the year 2020. This was followed with strict lockdowns and containment restriction in more than 200 countries across the globe. Hence, this led to serious disruptions in every business across each industry globally. For instance, the lockdowns restrictions lead to closure of non-essential business worldwide. Only, the essential businesses such as healthcare facilities with COVD-19 focus operated during the pandemic.
COVID-19 exhibited a positive impact on metabolomics market. This was due to the fact that metabolomics was vastly applied in the research related to studying the effect of COVID-19 on human body. Metabolomics were used to analyze alterations in the plasma metabolone which reflected the clinical presentation of COVID-19 patients. Hence, the rise in demand for metabolomics products during COVID-19 led to surge in growth of metabolomics market thereby exhibiting a positive impact on the market.
By product segment, the largest market for metabolomics is metabolomics bioinformatics due to a huge number of utilization in metabolomics analysis tool and services. Owing to increased demand for data management, it is anticipated to grow at the highest CAGR during the forecast period.
By application segment the largest market in metabolomics is biomarker discovery due to technological advancement in discovery technologies, an upsurge in incidences of chronic diseases, increase in demand for personalized healthcare, and growth in recognitions for modern diagnostics tests.
Key Findings Of The Study
- By product, the metabolomics bioinformatics tool and services segment was the highest contributor to the metabolomics market in 2020
- On the basis of application, the biomarker discovery segment dominated the market in 2020, personalized medicine is expected to continue this trend during the forecast period
- Depending on indication, cancer segment led the market in 2020; neurological disorder market is anticipated to grow at the highest CAGR during the forecast period
- Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- Agilent Technologies INC.
- BiocratesLife Science AG
- Bio-Rad Laboratories INC.
- Bruker corporation
- Danaher Corporation
- Human Metabolome Technologies INC.
- LECO Corporation
- Metabolon INC.
- Shimadzu Corporation
- Water Corporation.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
